{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces\r\n","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. \r\n"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","metadata_created":"2019-01-17T21:41:39.539843","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2019-01-17T21:41:39.539851","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2019-01-17","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["connaissances","études qualitatives","aperçus","vaccins","vaccination","Comité consultatif national de l'immunisation","vaccin contre l'hépatite A","l'immunisation de la mère","vaccins contre la grippe"],"en":["Scientific writing","implementing science articles","qualitative studies","vaccine safety","Ontario's Universal Influenza Immunization Program","yellow fever vaccine","immunization","seasonal influenza vaccine","Hepatitis A vaccine","Environmental Assessment","Protection Against Influenza","Maternal Immunization"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"RMTC : Volume 42-9, le 1er septembre 2016 : Rédaction scientifique","en":"CCDR: Volume 42-9, September 1, 2016: Scientific writing"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"e230769b-e1f5-4451-9676-8392f51edba9","related_relationship":"","name_translated":{"fr":"RMTC : Volume 42-9, le 1er septembre 2016 : Rédaction scientifique","en":"CCDR: Volume 42-9, September 1, 2016: Scientific writing"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 42-9, September 1, 2016: Scientific writing","language":["en"],"created":"2019-01-17T21:41:39.981052","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-9-september-1-2016.html","last_modified":null,"position":0,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"78a844d1-9f1f-4114-bf6a-c79c667a4008","related_relationship":"","name_translated":{"fr":"RMTC : Volume 42-9, le 1er septembre 2016 : Rédaction scientifique","en":"CCDR: Volume 42-9, September 1, 2016: Scientific writing"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 42-9, September 1, 2016: Scientific writing","language":["fr"],"created":"2019-01-17T21:41:39.981061","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016.html","last_modified":null,"position":1,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"id":"213b0608-445d-4dbe-853c-84747ba9c92b","character_set":"","state":"active","name_translated":{"fr":"RMTC : Volume 42-9, le 1er septembre 2016 : Rédaction scientifique","en":"CCDR: Volume 42-9, September 1, 2016: Scientific writing"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 42-9, September 1, 2016: Scientific writing","language":["en"],"created":"2019-01-17T21:41:39.981064","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/16vol42/dr-rm42-9/assets/pdf/16vol42_9-eng.pdf","last_modified":null,"position":2,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"id":"4baa1383-184c-4e10-ae06-6a2529d856f5","character_set":"","state":"active","name_translated":{"fr":"RMTC : Volume 42-9, le 1er septembre 2016 : Rédaction scientifique","en":"CCDR: Volume 42-9, September 1, 2016: Scientific writing"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 42-9, September 1, 2016: Scientific writing","language":["fr"],"created":"2019-01-17T21:41:39.981067","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/16vol42/dr-rm42-9/assets/pdf/16vol42_9-fra.pdf","last_modified":null,"position":3,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"dceff59d-122e-479a-b8dd-fc86dc2456f4","related_relationship":"","name_translated":{"fr":"Guide de présentation des rapports sur la science de l'application des connaissances - 2016","en":"Implementation science reporting guide - 2016 "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Implementation science reporting guide - 2016 ","language":["en"],"created":"2019-01-17T21:41:39.981069","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/16vol42/dr-rm42-9/assets/pdf/16vol42_9-eng.pdf","last_modified":null,"position":4,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"25182aa6-c272-443c-be99-45c15e528444","related_relationship":"","name_translated":{"fr":"Guide de présentation pour les études qualitatives - 2016","en":"Qualitative studies reporting guide - 2016 "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Qualitative studies reporting guide - 2016 ","language":["fr"],"created":"2019-01-17T21:41:39.981071","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016/rmtc-volume-42-9-1er-septembre-2016-redaction-scientifique-1.html","last_modified":null,"position":5,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"64ba9b23-55c6-4f78-b3d4-bbc2a77a4c9d","related_relationship":"","name_translated":{"fr":"Guide de présentation pour les aperçus - 2016 ","en":"Overviews reporting guide - 2016 "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Overviews reporting guide - 2016 ","language":["en"],"created":"2019-01-17T21:41:39.981074","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-9-september-1-2016/ccdr-volume-42-9-september-1-2016-scientific-writing-2.html","last_modified":null,"position":6,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"fcc29a15-f759-4d1e-b802-4cb7a916097f","related_relationship":"","name_translated":{"fr":"Guide de présentation pour les aperçus - 2016 ","en":"Overviews reporting guide - 2016 "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Overviews reporting guide - 2016 ","language":["fr"],"created":"2019-01-17T21:41:39.981076","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016/rmtc-volume-42-9-1er-septembre-2016-redaction-scientifique-2.html","last_modified":null,"position":7,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"5de14f4b-8d68-43b0-8e56-14004aa536c8","related_relationship":"","name_translated":{"fr":"Innocuité des vaccins contre la grippe en Ontario","en":"Influenza vaccine safety in Ontario"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Influenza vaccine safety in Ontario","language":["en"],"created":"2019-01-17T21:41:39.981079","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-9-september-1-2016/ccdr-volume-42-9-september-1-2016-scientific-writing-3.html","last_modified":null,"position":8,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d1e6d251-8419-47b5-ac96-82a4b50162f1","related_relationship":"","name_translated":{"fr":"Innocuité des vaccins contre la grippe en Ontario","en":"Influenza vaccine safety in Ontario"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Influenza vaccine safety in Ontario","language":["fr"],"created":"2019-01-17T21:41:39.981081","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016/rmtc-volume-42-9-1er-septembre-2016-redaction-scientifique-3.html","last_modified":null,"position":9,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"763b126f-47fb-4eb6-92e5-c0c4b02bf145","related_relationship":"","name_translated":{"fr":"Utilisation du vaccin contre la fièvre jaune au Canada durant une pénurie du vaccin","en":"Use of yellow fever vaccine in Canada during a vaccine shortage"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Use of yellow fever vaccine in Canada during a vaccine shortage","language":["en"],"created":"2019-01-17T21:41:39.981083","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-9-september-1-2016/ccdr-volume-42-9-september-1-2016-scientific-writing-4.html","last_modified":null,"position":10,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"e87aa780-2cc7-4ec5-8279-0ccf04755e28","related_relationship":"","name_translated":{"fr":"Utilisation du vaccin contre la fièvre jaune au Canada durant une pénurie du vaccin","en":"Use of yellow fever vaccine in Canada during a vaccine shortage"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Use of yellow fever vaccine in Canada during a vaccine shortage","language":["fr"],"created":"2019-01-17T21:41:39.981086","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016/rmtc-volume-42-9-1er-septembre-2016-redaction-scientifique-3.html","last_modified":null,"position":11,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"0173b32c-22c0-4e6f-ad8a-e1e4ea436723","related_relationship":"","name_translated":{"fr":"Déclaration du CCNI sur la vaccination antigrippale pour la saison 2016-2017","en":"NACI Statement on Seasonal Influenza Vaccine: 2016–2017"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"NACI Statement on Seasonal Influenza Vaccine: 2016–2017","language":["en"],"created":"2019-01-17T21:41:39.981088","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-9-september-1-2016/ccdr-volume-42-9-september-1-2016-scientific-writing-5.html","last_modified":null,"position":12,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"3083246f-d357-4214-970c-95cad89e866b","related_relationship":"","name_translated":{"fr":"Déclaration du CCNI sur la vaccination antigrippale pour la saison 2016-2017","en":"NACI Statement on Seasonal Influenza Vaccine: 2016–2017"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"NACI Statement on Seasonal Influenza Vaccine: 2016–2017","language":["fr"],"created":"2019-01-17T21:41:39.981090","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016/rmtc-volume-42-9-1er-septembre-2016-redaction-scientifique-5.html","last_modified":null,"position":13,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"2e5050db-f657-48e1-937f-4cf9403607d4","related_relationship":"","name_translated":{"fr":"Déclaration du CCNI sur l'utilisation du vaccin contre l'hépatite A","en":"NACI Statement on use of Hepatitis A vaccine"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"NACI Statement on use of Hepatitis A vaccine","language":["en"],"created":"2019-01-17T21:41:39.981093","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-9-september-1-2016/ccdr-volume-42-9-september-1-2016-scientific-writing-6.html","last_modified":null,"position":14,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d5be7b73-e54e-4df9-99fc-911b0b038afc","related_relationship":"","name_translated":{"fr":"Déclaration du CCNI sur l'utilisation du vaccin contre l'hépatite A","en":"NACI Statement on use of Hepatitis A vaccine"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"NACI Statement on use of Hepatitis A vaccine","language":["fr"],"created":"2019-01-17T21:41:39.981095","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016/rmtc-volume-42-9-1er-septembre-2016-redaction-scientifique-6.html","last_modified":null,"position":15,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"02be62ec-f791-41f2-818f-f6eef2d5fde0","related_relationship":"","name_translated":{"fr":"Évaluation environnementale pour l'utilisation expérimentale du moustique Aedes aegypti OX513A","en":"Environmental Assessment for Investigational Use of Aedes aegypti OX513A"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Environmental Assessment for Investigational Use of Aedes aegypti OX513A","language":["en"],"created":"2019-01-17T21:41:39.981097","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-9-september-1-2016/ccdr-volume-42-9-september-1-2016-scientific-writing-7.html#a2","last_modified":null,"position":16,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"0679f616-c055-4a58-87f6-262397d18c8f","related_relationship":"","name_translated":{"fr":"Évaluation environnementale pour l'utilisation expérimentale du moustique Aedes aegypti OX513A","en":"Environmental Assessment for Investigational Use of Aedes aegypti OX513A"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Environmental Assessment for Investigational Use of Aedes aegypti OX513A","language":["fr"],"created":"2019-01-17T21:41:39.981100","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016/rmtc-volume-42-9-1er-septembre-2016-redaction-scientifique-7.html","last_modified":null,"position":17,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"f9cae064-faeb-40d8-866f-fca6c0cba552","related_relationship":"","name_translated":{"fr":"Durée de la protection du nourrisson contre la grippe conférée par l'immunisation de la mère : Analyse secondaire d'un essai clinique randomisé","en":"Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial","language":["en"],"created":"2019-01-17T21:41:39.981102","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-9-september-1-2016/ccdr-volume-42-9-september-1-2016-scientific-writing-7.html#a2","last_modified":null,"position":18,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6cfbe5e5-2e47-4682-b553-b17fd60a6978","related_relationship":"","name_translated":{"fr":"Durée de la protection du nourrisson contre la grippe conférée par l'immunisation de la mère : Analyse secondaire d'un essai clinique randomisé","en":"Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization: Secondary Analysis of a Randomized Clinical Trial","language":["fr"],"created":"2019-01-17T21:41:39.981104","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016/rmtc-volume-42-9-1er-septembre-2016-redaction-scientifique-7.html","last_modified":null,"position":19,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8688461f-453e-46a9-b539-5723df2b76c6","related_relationship":"","name_translated":{"fr":"Guide de présentation des rapports sur la science de l'application des connaissances - 2016","en":"Implementation science reporting guide - 2016 "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Implementation science reporting guide - 2016 ","language":["fr"],"created":"2019-01-17T21:41:39.981107","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-9-1er-septembre-2016/rmtc-volume-42-9-1er-septembre-2016-redaction-scientifique.html","last_modified":null,"position":20,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"225123ae-03ff-48b4-838a-3f39c83c0187","related_relationship":"","name_translated":{"fr":"Guide de présentation pour les études qualitatives - 2016","en":"Qualitative studies reporting guide - 2016 "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Qualitative studies reporting guide - 2016 ","language":["en"],"created":"2019-01-17T21:41:39.981109","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-9-september-1-2016/ccdr-volume-42-9-september-1-2016-scientific-writing-1.html","last_modified":null,"position":21,"revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392","resource_type":"website"}],"place_of_publication":[],"num_resources":22,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2016-09-01 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"39dbb44a-e407-457e-97c1-d7689c8d5ec3","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. \r\n","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR: Volume 42-9, September 1, 2016: Scientific writing","revision_id":"1e6b60f9-9f98-4dbc-82e6-4c77a80f1392"}